GOLIM4

Across TCGA pan-cancer cohorts, GOLIM4 mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of GOLIM4’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where GOLIM4 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types GOLIM4 is over-expressed in tumor.

HNSC, PDAC, and COAD are the cancer types where GOLIM4 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GOLIM4 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	IV	+1.109	<.001	12	view →
PDAC	Female	II,III,IV	+0.653	<.001	10	view →
COAD	Male	All	+0.263	<.001	8	view →
LSCC	Male	III,IV	+0.583	<.001	7	view →
LUAD	Male	All	+0.220	<.001	6	view →
CCRCC	All	All	+0.141	<.001	6	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

GOLIM4–HNSC

Open the HNSC breakdown →